{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:05:47Z","timestamp":1789070747898,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/ncpendmet1006","type":"journal-article","created":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T08:43:58Z","timestamp":1227602638000},"page":"55-61","source":"Crossref","is-referenced-by-count":30,"title":["A patient with stress-related onset and exacerbations of Graves disease"],"prefix":"10.1038","volume":"5","author":[{"given":"Roberto","family":"Vita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"BFncpendmet1006_CR1","first-page":"374","volume-title":"Williams Textbook of Endocrinology","author":"TF Davies","year":"2003","unstructured":"Davies TF and Larsen PR (2003) Thyrotoxicosis. In Williams Textbook of Endocrinology, edn 10, 374\u2013421 (Eds Larsen PR  et al.) Philadelphia, PA: Saunders"},{"issue":"Suppl","key":"BFncpendmet1006_CR2","first-page":"S41","volume":"92","author":"M Abalovich","year":"2007","unstructured":"Abalovich M  et al. (2007) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92 (Suppl): S41\u2013S47","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1006_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/ncpendmet0508","volume":"3","author":"GW Chan","year":"2007","unstructured":"Chan GW and Mandel SJ (2007) Therapy Insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocr Metab 3: 470\u2013478","journal-title":"Nat Clin Pract Endocr Metab"},{"key":"BFncpendmet1006_CR4","first-page":"665","volume-title":"Werner and Ingbars' The Thyroid: A Fundamental and Clinical Text","author":"DS Cooper","year":"2005","unstructured":"Cooper DS (2005) Treatment of thyrotoxicosis. In Werner and Ingbars' The Thyroid: A Fundamental and Clinical Text, edn 9, 665\u2013694 (Eds Braverman LE and Utiger RD) Philadelphia, PA: Lippincott Williams & Wilkins"},{"key":"BFncpendmet1006_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jcem-6-1-1","volume":"6","author":"RH Williams","year":"1946","unstructured":"Williams RH (1946) Thiouracil treatment of thyrotoxicosis. J Clin Endocrinol Metab 6: 1\u201322","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1006_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1365-2265.1998.00450.x","volume":"48","author":"TH Brix","year":"1998","unstructured":"Brix TH  et al. (1998) A population-based study of Graves' disease in Danish twins. Clin Endocrinol 48: 397\u2013400","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet1006_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MED.0b013e3282ef1c48","volume":"14","author":"F Guarneri","year":"2007","unstructured":"Guarneri F and Benvenga S (2007) Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diabetes Obes 14: 398\u2013409","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"BFncpendmet1006_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/thy.2004.14.1047","volume":"14","author":"T Mizokami","year":"2004","unstructured":"Mizokami T  et al. (2004) Stress and thyroid autoimmunity. Thyroid 14: 1047\u20131055","journal-title":"Thyroid"},{"key":"BFncpendmet1006_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000104859","volume":"13","author":"M Bagnasco","year":"2006","unstructured":"Bagnasco M  et al. (2006) Stress and autoimmune thyroid diseases. Neuroimmunomodulation 13: 309\u2013317","journal-title":"Neuroimmunomodulation"},{"key":"BFncpendmet1006_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00006842-199809000-00014","volume":"60","author":"K Yoshiuchi","year":"1998","unstructured":"Yoshiuchi K  et al. (1998) Psychosocial factors influencing the short-term outcome of antithyroid drug therapy in Graves' disease. Psychosom Med 60: 592\u2013596","journal-title":"Psychosom Med"},{"key":"BFncpendmet1006_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1046\/j.1365-2265.2003.01625.x","volume":"58","author":"A Fukao","year":"2003","unstructured":"Fukao A  et al. (2003) The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease. Clin Endocrinol (Oxf) 58: 550\u2013555","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet1006_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/eje.0.1500605","volume":"150","author":"M Prummel","year":"2004","unstructured":"Prummel M  et al. (2004) The environment and autoimmune thyroid diseases. Eur J Endocrinol 150: 605\u2013618","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1006_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000181094","volume":"31","author":"J Leclere","year":"1989","unstructured":"Leclere J and Werhya G (1989) Stress and auto-immune endocrine disease. Horm Res 31: 90\u201393","journal-title":"Horm Res"},{"key":"BFncpendmet1006_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1210\/edrv-7-2-149","volume":"7","author":"B Ahren","year":"1986","unstructured":"Ahren B (1986) Thyroid neuroendocrinology: neural regulation of thyroid hormone secretion. Endocr Rev 7: 149\u2013155","journal-title":"Endocr Rev"},{"key":"BFncpendmet1006_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.iy.05.040187.003201","volume":"5","author":"M Plaut","year":"1987","unstructured":"Plaut M (1987) Lymphocyte hormone receptors. Annu Rev Immunol 5: 621\u2013669","journal-title":"Annu Rev Immunol"},{"key":"BFncpendmet1006_CR16","first-page":"1206","volume-title":"Cecil Textbook of Medicine","author":"PR Larsen","year":"1982","unstructured":"Larsen PR (1982) Graves' disease and other causes of hyperthyroidism. In Cecil Textbook of Medicine, edn 17, 1206\u20131213 (Eds Wyngarden JB and Smith LH Jr) Philadelphia, PA: Saunders"},{"key":"BFncpendmet1006_CR17","first-page":"772","volume-title":"Trattato Italiano di Endocrinologia","author":"L Baschieri","year":"1977","unstructured":"Baschieri L  et al. (1977) Sindromi ipertiroidee. In Trattato Italiano di Endocrinologia, 772\u2013799 (Eds Cassano C and Andreani D) Rome, Italy: Societ\u00e0 Editrice Univero"},{"key":"BFncpendmet1006_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/thy.1996.6.659","volume":"6","author":"S Benvenga","year":"1996","unstructured":"Benvenga S (1996) Benzodiazepine and remission of Graves' disease. Thyroid 6: 659\u2013660","journal-title":"Thyroid"},{"key":"BFncpendmet1006_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neures.2005.03.011","volume":"52","author":"C Constaninou","year":"2005","unstructured":"Constaninou C  et al. (2005) Diazepam affects the nuclear thyroid hormone receptor density and their expression levels in adult rat brain. Neurosci Res 52: 269\u2013275","journal-title":"Neurosci Res"},{"key":"BFncpendmet1006_CR20","first-page":"1211","volume":"130","author":"L Kragie","year":"1992","unstructured":"Kragie L and Doyle D (1992) Benzodiazepines inhibit temperature-dependent L-[125I]triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines. Endocrinology 130: 1211\u20131216","journal-title":"Endocrinology"},{"key":"BFncpendmet1006_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/002215540405200103","volume":"52","author":"E Bribes","year":"2004","unstructured":"Bribes E  et al. (2004) Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues. J Histochem Cytochem 52: 19\u201328","journal-title":"J Histochem Cytochem"},{"key":"BFncpendmet1006_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0014-2999(02)02231-8","volume":"452","author":"E Bribes","year":"2002","unstructured":"Bribes E  et al. (2002) Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl\/lpr mice. Eur J Pharmacol 452: 111\u2013122","journal-title":"Eur J Pharmacol"},{"key":"BFncpendmet1006_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","volume":"53","author":"MM Iqbal","year":"2002","unstructured":"Iqbal MM  et al. (2002) Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 53: 39\u201343","journal-title":"Psychiatr Serv"},{"key":"BFncpendmet1006_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","volume":"317","author":"LR Dolovich","year":"1998","unstructured":"Dolovich LR  et al. (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 317: 839\u2013843","journal-title":"BMJ"},{"key":"BFncpendmet1006_CR25","first-page":"2121","volume":"61","author":"LP Longo","year":"2000","unstructured":"Longo LP and Johnson B (2000) Addiction: Part I. Benzodiazepines\u2014side effects, abuse risk and alternatives. Am Fam Physician 61: 2121\u20132128","journal-title":"Am Fam Physician"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1006","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:57:41Z","timestamp":1684439861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet1006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFncpendmet1006"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet1006","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}